Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The DOD studies seek to test the effectiveness of PLX-R18 as a novel medical countermeasure for Acute Radiation Syndrome (ARS) prior to and within 24 hours of exposure to high levels of radiationThe...
-
HAIFA, Israel, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that it has been...
-
Findings pave the way to potentially use PLX-R18 to support hematological recovery following radiotherapy or chemotherapyData focuses on 12 additional NHPs that were exposed to lower radiation levels ...
-
Austria’s regulatory health agency clears CLI study and joins the U.S., U.K., and Germany in conducting the 250-patient Phase III trial HAIFA, Israel, July 10, 2017 (GLOBE NEWSWIRE) -- Pluristem...
-
HAIFA, Israel, June 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that new data...
-
HAIFA, Israel, May 22, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial results...
-
All PLX-treated groups showed improvements in survival rates compared to untreated groups PLX-R18 cells did not increase leukocyte levels in non-irradiated NHPs, indicating no requirement to determine...
-
In addition, Pluristem has over 110 pending patent applications.The patents portfolio covers over 30 different innovations across major markets. HAIFA, Israel, April 19, 2017 (GLOBE NEWSWIRE) --...
-
HAIFA, Israel, March 30, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI), (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced advancement in...
-
Yaky Yanay appointed Co-Chief Executive Officer to serve together with Co-Chief Executive Officer Zami AbermanErez Egozi appointed as Chief Financial Officer HAIFA, Israel, March 29, 2017 (GLOBE...